Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Matsuzawa T is active.

Publication


Featured researches published by Matsuzawa T.


Gastrointestinal Endoscopy | 2015

A Japanese prospective multicenter study of self-expandable metal stent placement for malignant colorectal obstruction: short-term safety and efficacy within 7 days of stent procedure in 513 cases.

Matsuzawa T; Hideyuki Ishida; Shuntaro Yoshida; Hiroyuki Isayama; Toshio Kuwai; Iruru Maetani; Mamoru Shimada; Tomonori Yamada; Shuji Saito; Masafumi Tomita; Koichi Koizumi; Nobuto Hirata; Takashi Sasaki; Toshiyuki Enomoto; Yoshihisa Saida

BACKGROUND Endoscopic self-expandable metal stent placement has been used as an alternative to surgery for malignant colorectal obstruction; however, factors affecting its clinical outcome are unclear. OBJECTIVE To clarify the short-term safety and efficacy of endoscopic self-expandable metal stent placement for malignant colorectal obstruction and to identify factors associated with its clinical and technical failure. DESIGN Prospective clinical cohort study. SETTING Fourteen academic centers and 32 community hospitals. PATIENTS A total of 513 consecutive patients with malignant colorectal obstruction. INTERVENTION Endoscopic self-expandable metal stent placement, sharing of stent placement methods among participating facilities. MAIN OUTCOME MEASUREMENTS The primary endpoint was clinical success, defined as symptom and radiological finding resolution within 24 hours. Secondary endpoints were technical success and adverse events. The follow-up period was 7 days. RESULTS The clinical and technical success rates were 95.5% and 97.9%, respectively. Major adverse events included perforation (2.1%), stent migration (1.0%), and stent occlusion (0.8%). The main causes of perforation were the procedure itself (0.8%) and comorbidities (obstructive colitis and impending perforation) not apparent before stent placement (0.6%). Extrinsic tumor origin was independently associated with the clinical failure after stent placement (odds ratio 4.23; 95% confidence interval, 1.21-14.79; P = .02). Stricture marking trended toward a negative association with technical failure (P = .09). LIMITATIONS Noncomparative study. CONCLUSION Strict inclusion criteria and stricture marking may improve the technical and clinical success of stent placement.


International Surgery | 2017

Do the types of perforation impact the outcomes in perforated stage II/III colorectal cancer patients?

Hisashi Onozawa; Kensuke Kumamoto; Matsuzawa T; Toru Ishiguro; Jun Sobajima; Minoru Fukuchi; Youichi Kumagai; Keiichiro Ishibashi; Erito Mochiki; Hideyuki Ishida

Purpose: To compare the oncological outcomes between colorectal cancer (CRC) patients with tumor perforation and those with perforation proximal to the tumor. Patients and methods: Medical charts of 39 patients who underwent emergency surgery for colonic perforation related to potentially curable CRC were reviewed. Results: Eighteen patients developed tumor perforation (group A), whereas 21 patients developed perforation proximal to the tumor (group B). Twenty-four patients were pathological stage II and 15 patients were stage III. There were no significant differences in the clinicopathological and surgical data, including hospital mortality, between the groups; however, the incidence of diffuse peritonitis was higher in group B than that in group A (P < 0.01). The induction rates of adjuvant chemotherapy for survivors were identical between the two groups. Disease-free and overall survival periods did not significantly differ between the groups. Conclusion: Perforation type was not found to be associate...


International Surgery | 2014

Production of Intraperitoneal Interleukin-6 Following Open or Laparoscopic Assisted Distal Gastrectomy

Youichi Kumagai; Yusuke Tajima; Toru Ishiguro; Haga N; Hideko Imaizumi; Okihide Suzuki; Koki Kuwabara; Matsuzawa T; Jun Sobajima; Minoru Fukuchi; Baba H; Keiichiro Ishibashi; Erito Mochiki; Hideyuki Ishida

The interleukin (IL)-6 concentration in plasma or serum has been considered to represent the degree of stress resulting from surgery. However, IL-6 in peritoneal fluid has rarely been considered. The aim of this study was to assess the concentration and amount of IL-6 in peritoneal fluid as indicators of surgical stress. To obtain basic data on peritoneal release of IL-6 during gastric cancer surgery, we measured IL-6 in peritoneal drainage samples, stored for up to 72 hours postoperatively, from patients who had undergone conventional open (ODG group, n = 20) and laparoscopic-assisted (LADG group, n = 19) distal gastrectomy. Within 24 hours, 61 and 77% of the IL-6 was released into the peritoneal cavity in the LADG and ODG groups, respectively. In both groups, the concentration and amount of peritoneal fluid IL-6 were significantly correlated with each other (LADG group: Spearmans rank correlation test [rS] = 0.48, P = 0.04; ODG group: rS = 0.58, P = 0.01). The concentration and amount of IL-6 in peritoneal fluid was 2.8- and 3.6-fold higher in the ODG than in the LADG group, respectively (P < 0.01). With regard to the relationship between the serum C-reactive protein (CRP) peak and the concentration or amount of peritoneal fluid IL-6 released within 24 hours, only the concentration of peritoneal fluid IL-6 in the LADG group was significantly correlated (rS = 0.60, P = 0.01) with the serum CRP peak. Our findings suggest that the amount and concentration of IL-6 released into the peritoneal cavity for up to 24 hours after surgery can each be a reliable parameter for assessment of surgical stress.


Surgical Endoscopy and Other Interventional Techniques | 2016

A prospective multicenter study on self-expandable metallic stents as a bridge to surgery for malignant colorectal obstruction in Japan: efficacy and safety in 312 patients

Shuji Saito; Shuntaro Yoshida; Hiroyuki Isayama; Matsuzawa T; Toshio Kuwai; Iruru Maetani; Mamoru Shimada; Tomonori Yamada; Masafumi Tomita; Koichi Koizumi; Nobuto Hirata; Hideki Kanazawa; Toshiyuki Enomoto; Hitoshi Sekido; Yoshihisa Saida


Anticancer Research | 2013

C-reactive Protein as a Significant Prognostic Factor for Stage IV Gastric Cancer Patients

Baba H; Koki Kuwabara; Toru Ishiguro; Hatano S; Matsuzawa T; Minoru Fukuchi; Kumagai Y; Keiichiro Ishibashi; Erito Mochiki; Hideyuki Ishida


Anticancer Research | 2013

C-Reactive Protein Is a Negative Independent Factor in Patients with Stage IV Colorectal Cancer Undergoing Oxaliplatin-based Chemotherapy

Minoru Fukuchi; Kohki Kuwabara; Yoshitaka Tsuji; Baba H; Keiichiro Ishibashi; Chika N; Hatano S; Matsuzawa T; Kensuke Kumamoto; Youichi Kumagai; Erito Mochiki; Hideyuki Ishida


Surgery Today | 2016

Comparison of the risk of surgical site infection and feasibility of surgery between sennoside versus polyethylene glycol as a mechanical bowel preparation of elective colon cancer surgery: a randomized controlled trial

Yusuke Tajima; Hideyuki Ishida; Azusa Yamamoto; Chika N; Hisashi Onozawa; Matsuzawa T; Kensuke Kumamoto; Keiichiro Ishibashi; Erito Mochiki


Gan to kagaku ryoho. Cancer & chemotherapy | 2012

[A long-term survivor of colorectal cancer associated with multiple liver metastases and peritoneal carcinomatosis treated through a multidisciplinary approach].

Tajima Y; Keiichiro Ishibashi; Matsuzawa T; Toru Ishiguro; Ohsawa T; Okada N; Kensuke Kumamoto; Kumagai Y; Baba H; Haga N; Hideyuki Ishida


International Surgery | 2014

Predicting the Amount of Intraperitoneal Fluid Accumulation by Computed Tomography and Its Clinical Use in Patients With Perforated Peptic Ulcer

Toru Ishiguro; Youichi Kumagai; Baba H; Yusuke Tajima; Hideko Imaizumi; Okihide Suzuki; Koki Kuwabara; Matsuzawa T; Jun Sobajima; Minoru Fukuchi; Keiichiro Ishibashi; Erito Mochiki; Hideyuki Ishida


Techniques in Coloproctology | 2013

Should isolated peritoneal carcinomatosis from colorectal cancer be sub-classified into stage IVB in era of modern chemotherapy?

Hideyuki Ishida; Kensuke Kumamoto; Keiichiro Ishibashi; Hatano S; Matsuzawa T; Okada N; Kumagai Y; Baba H; Haga N

Collaboration


Dive into the Matsuzawa T's collaboration.

Top Co-Authors

Avatar

Hideyuki Ishida

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Erito Mochiki

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar

Kumagai Y

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar

Kensuke Kumamoto

Fukushima Medical University

View shared research outputs
Top Co-Authors

Avatar

Baba H

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar

Minoru Fukuchi

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar

Hatano S

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar

Chika N

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar

Toru Ishiguro

Saitama Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge